Tamara Alonso
Overview
Explore the profile of Tamara Alonso including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
164
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rudilla D, Alonso T, Garcia E, Perez P, Valenzuela C, Giron R, et al.
Open Respir Arch
. 2024 Mar;
6(2):100304.
PMID: 38496265
Introduction: The patient experience is defined as all the interactions that occur between patients and the healthcare system. The experience of patients with respiratory disease with home respiratory treatments (HRT)...
2.
Roy-Vallejo E, Fernandez de Cordoba-Onate S, Delgado-Wicke P, Triguero-Martinez A, Montes N, Carracedo-Rodriguez R, et al.
Front Med (Lausanne)
. 2023 Oct;
10:1215246.
PMID: 37809329
Introduction: SARS-CoV-2 viral load has been related to COVID-19 severity. The main aim of this study was to evaluate the relationship between SARS-CoV-2 viremia and SNPs in genes previously studied...
3.
Keogan S, Alonso T, Sunday S, Hanafin J, Tigova O, Fernandez E, et al.
Int J Environ Res Public Health
. 2023 Jun;
20(11).
PMID: 37297582
Smokefree laws are intended to protect against second-hand smoke (SHS) in outdoor areas. We examined if exposure to PM2.5 particles in outdoor smoking areas changed breathing rates in 60 patients...
4.
Soriano J, Pelaez A, Busquets X, Rodrigo-Garcia M, Perez-Urria E, Alonso T, et al.
PLoS One
. 2023 Jun;
18(6):e0286769.
PMID: 37267401
Background: An association of ABO blood group and COVID-19 remains controversial. Methods: Following STROBE guidance for observational research, we explored the distribution of ABO blood group in patients hospitalized for...
5.
Herranz C, Mateo F, Baiges A, Ruiz de Garibay G, Junza A, Johnson S, et al.
EMBO Mol Med
. 2021 Aug;
13(9):e13929.
PMID: 34378323
Inhibition of mTOR is the standard of care for lymphangioleiomyomatosis (LAM). However, this therapy has variable tolerability and some patients show progressive decline of lung function despite treatment. LAM diagnosis...
6.
Rudilla D, Beceiro M, Alonso T, Oliver A, Soriano J, Valenzuela C, et al.
Arch Bronconeumol
. 2021 May;
58(2):191-193.
PMID: 34045108
No abstract available.
7.
Galvan-Roman J, Rodriguez-Garcia S, Roy-Vallejo E, Marcos-Jimenez A, Sanchez-Alonso S, Fernandez-Diaz C, et al.
J Allergy Clin Immunol
. 2020 Oct;
147(1):72-80.e8.
PMID: 33010257
Background: Patients with coronavirus disaese 2019 (COVID-19) can develop a cytokine release syndrome that eventually leads to acute respiratory distress syndrome requiring invasive mechanical ventilation (IMV). Because IL-6 is a...
8.
Keogan S, Alonso T, Sunday S, Tigova O, Fernandez E, Lopez M, et al.
J Asthma
. 2020 May;
58(9):1169-1175.
PMID: 32441557
Background: Further evidence is needed on the effects that short- and long-term exposure to secondhand smoke (SHS) have on the respiratory health of patients with lung disease. Within the TackSHS...
9.
Punter R, Giron Moreno R, Vazquez Espinosa E, Soriano J, Pastor M, Zamora E, et al.
Respir Care
. 2018 Nov;
64(1):48-54.
PMID: 30459242
Background: Nocturnal desaturation in cystic fibrosis (CF) may have prognostic implications because a significant and maintained nocturnal desaturation can contribute to the development and progression of pulmonary hypertension with cor...
10.
Alonso T, Castaneda S, Ancochea J
Arch Bronconeumol (Engl Ed)
. 2018 Jul;
54(11):549-550.
PMID: 30017254
No abstract available.